Oct 23, 2024 · Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for people 65 years and older and those who are moderately or severely immunocompromised to receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose.

Jan 7, 2025 · Everyone ages 6 months and older should get the 2024–2025 COVID-19 vaccine. This includes people who have received a COVID-19 vaccine, people who have had COVID …

Dec 9, 2024 · Three updated vaccines, which work two different ways, are authorized or licensed by the FDA for the 2024-2025 season: Novavax. A protein subunit vaccine, Novavax is authorized for emergency...

Oct 31, 2024 · People ages 65 years and older, vaccinated under the routine schedule, are recommended to receive 2 doses of any 2024–2025 COVID-19 vaccine (i.e., Moderna, Novavax, or Pfizer-BioNTech) separated by 6 months (minimum interval 2 months) regardless of vaccination history, with one exception: Unvaccinated people who initiate vaccination with 2024 ...

Dec 2, 2024 · What is a COVID-19 2-dose vaccine? The vaccine is given as a shot into a muscle in your shoulder area to help prevent COVID-19. Two doses are needed for full protection. The time between doses varies, depending on the vaccine you receive. Make an appointment to get the second dose at the time recommended by your healthcare provider.

Oct 25, 2024 · Adults 65 and older and people with weakened immune systems should get two doses of the newly updated COVID-19 vaccine, the Centers for Disease Control and Prevention (CDC) recommends.

Oct 24, 2024 · The COVID vaccine updated in 2023 was aimed at XBB.1.5, an Omicron subvariant that had been the dominant SARS-CoV-2 variant in the U.S. and the world at that …

Oct 25, 2024 · Immunocompromised people and those who are age 65 or older should get a second dose of the 2024-2025 COVID-19 vaccine, according to the latest recommendations …

Mar 5, 2021 · Some COVID-19 vaccines require two doses because the second dose helps to better reinforce the immune response. Learn more about vaccine immunity.

Oct 29, 2024 · The current mRNA vaccines from Moderna and Pfizer-BioNTech target the KP.2 variant, and the Novavax vaccine targets the JN.1 variant—neither of which are the dominant version causing...